RNA Based Therapeutics Market Size to touch USD 6.87 billion by 2027

Global RNA Based Therapeutics Market to reach USD 6.87 billion by 2027. Global RNA Based Therapeutics Market is valued at approximately USD 0.93 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 28.4% over the forecast period 2020-2027.

Healthcare sector have undertaken their attention to bring constancy to the RNA molecules in the body with limited bioavailability. For this, RNA therapeutics is being developed and when combined with protein/lipid nanoparticles deliver better stability. Despite being in a clinical research phase, the RNA therapeutics is being extensively discovered with a primary target to find a cure for unmet medical circumstances and rare diseases.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/3357824/   

According to the Joint United Nations Programme on HIV and AIDS (UNAIDS), in 2019, there were 1.7 million people were newly influenced by HIV, as compared to a 2.8 million population of adults in 1998. Similarly, in August 2018, BioNTech AG has entered into a research and development (R&D) collaboration with Pfizer to develop Messenger RNA (mRNA) -based influenza vaccines. These exciting strategic collaborations and partnerships lead to pioneering developments in the RNA-based therapeutics field. This, in turn, is expected to strengthen the market growth all over the world. However, the high cost of research and risk of failure, coupled with complications in drug delivery are the few major factors limiting the market growth over the forecast period of 2020-2027.

Since, this field is significantly based on research, the advancements in technology assist in expanding the market and its geographical area. Advancement of promising technologies, such as antisense technology, RNAi interference technology, and smart technology that provides optimistic future growth prospect to the market in the forthcoming period. Furthermore, the rise in prevalence of infectious diseases, along with the more intense product focus against technology are the few factors responsible for the high CAGR of the market during the forecast period.

Global RNA Based Therapeutics Market Competitive Landscape Analysis (Revenue, USD billion, 2020-2027)

  • Quark Pharmaceuticals, Inc.
  • Alnylam Pharmaceuticals, Inc.
  • Dicerna Pharmaceuticals, Inc.
  • Tekmira Pharmaceuticals Corp.
  • Benitec Biopharma Limited
  • Cenix BioScience GmbH
  • Genzyme Corporation
  • Silence Therapeutics PLC
  • Sirnaomics, Inc.

The regional analysis of the global RNA Based Therapeutics market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rapid adoption of new technologies and therapeutic for drug delivery, along with the presence of a significant number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in number of patients with chronic diseases, such as cancer and cardiovascular diseases, along with the improving healthcare infrastructure in developing countries, such as China and India, would create lucrative growth prospects for the RNA Based Therapeutics market across the Asia-Pacific region.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market.

To access a sample copy or view this report in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/global-rna-based-therapeutics-market-size-research   

Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Technology:

  • Enabling technologies (such as microarrays, labeling, purification, and others)
  • Enabled technologies (e.g., RNA Interference (RNAi) technologies and RNA antisense technologies)

By Application:

  • Cardiovascular
  • Kidney Diseases
  • Oncology
  • Infectious diseases
  • Metabolic disorders
  • Others

By End-User:

  • Research
  • Therapeutics
  • Diagnosis

Global RNA Based Therapeutics Market Regional Analysis (Revenue, USD billion, 2020-2027)

North America

  • U.S.
  • Canada

Europe

  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico

Rest of the World

Related Report:

U.S. Non-Invasive Prenatal Testing Market - Growth, Demand, Trends, Opportunity, Forecasts (2020 - 2027)

The United States Non-Invasive Prenatal Testing market is anticipated to grow over US$ 2.2 Billion by 2027. The growth in the U.S. Non-Invasive Prenatal Testing (NIPT) market is largely attributed to factors such as the high risk of chromosomal abnormalities with increasing maternal age, increase in incidences of chromosomal aneuploidies among fetus, development of advanced non-invasive prenatal testing products, rising awareness regarding non-invasive prenatal testing, rising focus on reimbursement for NIPT, increasing preference for non-invasive techniques over invasive methods and ACOG guidelines recommend NIPT for all pregnancies regardless of risk.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

Corporate Sales,

Market Study Report LLC

Phone: 1-302-273-0910

Toll Free: 1-866-764-2150

Email: sales@marketstudyreport.com    


 

 

Back to news